Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 538019, 24 pages
http://dx.doi.org/10.1155/2015/538019
Review Article

Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies

1NMR Research Centre, Indian Institute of Science, Bangalore 560012, India
2Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore 560012, India

Received 7 July 2014; Revised 13 October 2014; Accepted 20 October 2014

Academic Editor: Eileen M. McGowan

Copyright © 2015 Varsha P. Brahmkhatri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [77 citations]

The following is the list of published articles that have cited the current article.

  • Ying Jin, and Xinmin Yu, “Research progress of anti-tumor antibodies,” Cancer Research and Clinic, vol. 27, no. 8, pp. 572–576, 2015. View at Publisher · View at Google Scholar
  • Michael B. Ranke, “Insulin-like growth factor binding-protein-3 (IGFBP–3),” Best Practice & Research Clinical Endocrinology & Metabolism, 2015. View at Publisher · View at Google Scholar
  • Alan C Goldhamer, Michael Klaper, Afsoon Foorohar, and Toshia R Myers, “Water-only fasting and an exclusively plant foods diet in the management of stage IIIa, low-grade follicular lymphoma,” BMJ Case Reports, vol. 2015, 2015. View at Publisher · View at Google Scholar
  • Zhigang Wang, Pingfang Lu, Zhu Liang, Zhanfei Zhang, Weicheng Shi, Xiaobi Cai, and Chunyuan Chen, “Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell,” Growth Factors, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Man-Shiow Jiang, Xiaoyi Yang, Dominic Esposito, Earl Nelson, Jinhui Yuan, Ralph F. Hopkins, Trevor Broadt, Zhen Xiao, Simona Colantonio, DaRue A. Prieto, Anthony R. Welch, Stephen P. Creekmore, George Mitra, and Jianwei Zhu, “Mammalian cell transient expression, non-affinity purification, and characterization of human recombinant IGFBP7, an IGF-1 targeting therapeutic protein,” International Immunopharmacology, 2015. View at Publisher · View at Google Scholar
  • Dubrovskaya, and Netrebenko, “Proteins in complementary food: What is the healthiest level?,” Voprosy Sovremennoi Pediatrii - Current Pediatrics, vol. 14, no. 3, pp. 387–391, 2015. View at Publisher · View at Google Scholar
  • Anastassios Philippou, Panagiotis F. Christopoulos, and Dr. Michael Koutsilieris, “Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer,” Mutation Research/Reviews in Mutation Research, 2016. View at Publisher · View at Google Scholar
  • Hamid Nickho, Mehdi Yousefi, Morteza Motallebnezhad, Leili Aghebati-Maleki, Farhad Jadidi-Niaragh, Hosein Samadi-Kafil, and Karim Shamsasenjan, “The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies,” Tumor Biology, vol. 37, no. 9, pp. 11711–11721, 2016. View at Publisher · View at Google Scholar
  • Adam F. Tracz, Cezary Szczylik, Camillo Porta, and Anna M. Czarnecka, “Insulin-like growth factor-1 signaling in renal cell carcinoma,” BMC Cancer, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Jing Han, Jian-Guo Sun, Feng-Yi Zhao, Xie-Wan Chen, Jiang Wang, Xu-Dong Wang, and Zheng-Tang Chen, “MiR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor,” International Journal of Molecular Medicine, vol. 38, no. 1, pp. 183–191, 2016. View at Publisher · View at Google Scholar
  • Régia Caroline Peixoto Lira, Paola Fernanda Fedatto, David Santos Marco Antonio, Letícia Ferro Leal, Carlos Eduardo Martinelli, Margaret de Castro, Silvio Tucci, Luciano Neder, Leandra Ramalho, Ana Luiza Seidinger, Izilda Cardinalli, Maria José Mastellaro, José Andres Yunes, Silvia Regina Brandalise, Luiz Gonzaga Tone, Sonir Roberto Rauber Antonini, and Carlos Alberto Scrideli, “ IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis ,” Endocrine-Related Cancer, vol. 23, no. 6, pp. 481–493, 2016. View at Publisher · View at Google Scholar
  • Jing Ding, Cong Li, Jie Tang, Cheng Yi, Ji-Yan Liu, and Meng Qiu, “Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus,” Pathology & Oncology Research, 2016. View at Publisher · View at Google Scholar
  • Gerhard Hamilton, Maximilian Hochmair, Barbara Rath, Lukas Klameth, and Robert Zeillinger, “Small cell lung cancer: circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.,” Cell Adhesion & Migration, pp. 00–00, 2016. View at Publisher · View at Google Scholar
  • Morteza Motallebnezhad, Leili Aghebati-Maleki, Elham Safarzadeh, Majid Ahmadi, Vahid Younesi, Hamid Nickho, Ali Akbar Movassaghpour, Ahmad Hosseini, and Mehdi Yousefi, “Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells,” Tumor Biology, vol. 37, no. 11, pp. 14841–14850, 2016. View at Publisher · View at Google Scholar
  • Lu Han, Guo-Feng Zhang, Yue-Hu Cheng, and Qi-Cheng Zhao, “Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer,” Japanese Journal of Clinical Oncology, 2016. View at Publisher · View at Google Scholar
  • Judy R. van Beijnum, Wietske Pieters, Patrycja Nowak-Sliwinska, and Arjan W. Griffioen, “Insulin-like growth factor axis targeting in cancer and tumour angiogenesis - the missing link,” Biological Reviews, 2016. View at Publisher · View at Google Scholar
  • Megan E. Zavorka, Christopher M. Connelly, Rosslyn Grosely, and Richard G. MacDonald, “Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor,” Oncotarget, vol. 7, no. 38, pp. 62386–62410, 2016. View at Publisher · View at Google Scholar
  • Liesbeth Bieghs, Elke De Bruyne, Eline Menu, Mette Nyegaard, Cheryl A. Conover, Karin Vanderkerken, Hans E. Johnsen, Ken Maes, Els Van Valckenborgh, and Michael T. Overgaard, “The insulin-like growth factor system in Multiple Myeloma: Diagnostic and therapeutic potential,” Oncotarget, vol. 7, no. 30, pp. 48732–48752, 2016. View at Publisher · View at Google Scholar
  • Cesar Luiz Boguszewski, Margaret Cristina Da Silva Boguszewski, and John J. Kopchick, “Growth hormone, insulin-like growth factor system, and carcinogenesis,” Endokrynologia Polska, vol. 67, no. 4, pp. 414–426, 2016. View at Publisher · View at Google Scholar
  • Rosa Divella, Raffaele De Luca, Ines Abbate, Emanuele Naglieri, and Antonella Daniele, “Obesity and cancer: The role of adipose tissue and adipo-cytokines-induced chronic inflammation,” Journal of Cancer, vol. 7, no. 15, pp. 2346–2359, 2016. View at Publisher · View at Google Scholar
  • Binyao Yang, Lisha Zhang, Yi Cao, Shuai Chen, Jun Cao, Di Wu, Jiansong Chen, Huali Xiong, Zihua Pan, Fuman Qiu, Jinbin Chen, Xiaoxuan Ling, Maosheng Yan, Suli Huang, Shiyu Zhou, Tiegang Li, Lei Yang, Yunchao Huang, and Jiachun Lu, “Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression,” Molecular Cancer, vol. 16, no. 1, 2017. View at Publisher · View at Google Scholar
  • Maria Mytilinaiou, Dragana Nikitovic, Aikaterini Berdiaki, Antonis Papoutsidakis, Dionysios J. Papachristou, Aristidis Tsatsakis, and George N. Tzanakakis, “IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis,” Experimental Cell Research, 2017. View at Publisher · View at Google Scholar
  • Ling-Hong Miao, Wen-Jing Pan, Yan Lin, Xian-Ping Ge, Bo Liu, Ming-Chun Ren, and Qun-Lan Zhou, “Bioinformatic prediction and analysis of glucolipid metabolic regulation by miR-34a in Megalobrama amblycephala,” Genes & Genomics, 2017. View at Publisher · View at Google Scholar
  • Aaron Simpson, Wilfride Petnga, Valentine M. Macaulay, Ulrike Weyer-Czernilofsky, and Thomas Bogenrieder, “Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies,” Targeted Oncology, 2017. View at Publisher · View at Google Scholar
  • Wang-Soo Lee, and Jaetaek Kim, “Insulin-like growth factor-1 signaling in cardiac aging,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017. View at Publisher · View at Google Scholar
  • Li-Li Mei, Yun-Tan Qiu, Meng-Bing Huang, Wen-Jun Wang, Jie Bai, and Zhi-Zhou Shi, “MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway,” Cancer Biomarkers, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Massimo Terzolo, Giuseppe Reimondo, Paola Berchialla, Emanuele Ferrante, Elena Malchiodi, Laura De Marinis, Rosario Pivonello, Silvia Grottoli, Marco Losa, Salvatore Cannavo, Diego Ferone, Marcella Montini, Marta Bondanelli, Ernesto De Menis, Chiara Martini, Efisio Puxeddu, Antonino Velardo, Alessandro Peri, Marco Faustini-Fustini, Patrizia Tita, Francesca Pigliaru, Giulia Peraga, Giorgio Borretta, Carla Scaroni, Nicoletta Bazzoni, Antonio Bianchi, Alessandro Berton, Andreea Liliana Serban, Roberto Baldelli, Letizia Maria Fatti, Annamaria Colao, and Maura Arosio, “Acromegaly is associated with increased cancer risk: a survey in Italy,” Endocrine-Related Cancer, vol. 24, no. 9, pp. 495–504, 2017. View at Publisher · View at Google Scholar
  • David Kalfert, Martin Pesta, Jan Plzak, Marie Ludvikova, Ondrej Topolcan, Petr Celakovsky, Radek Kucera, Jindra Windrichova, Jaroslav Ludvik, Katerina Skalova, and Vlastimil Kulda, “Serum levels of IGF-1 and IGFBP-3 in relation to clinical and pathobiological aspects of head and neck squamous cell carcinomas,” Anticancer Research, vol. 37, no. 6, pp. 3281–3286, 2017. View at Publisher · View at Google Scholar
  • Jaafar Bennouna, “ Update on afatinib-based combination regimens for the treatment of EGFR mutation-positive non-small-cell lung cancer ,” Future Oncology, 2017. View at Publisher · View at Google Scholar
  • Arathy S. Kumar, Suresh K. Rayala, and Ganesh Venkatraman, “Targeting IGF1R pathway in cancer with microRNAs: How close are we ?,” RNA Biology, pp. 00–00, 2017. View at Publisher · View at Google Scholar
  • Roudy Chiminch Ekyalongo, and Douglas Yee, “Revisiting the IGF-1R as a breast cancer target,” npj Precision Oncology, vol. 1, no. 1, 2017. View at Publisher · View at Google Scholar
  • Mark Messina, and Pamela Magee, “Does soy protein affect circulating levels of unbound IGF-1?,” European Journal of Nutrition, 2017. View at Publisher · View at Google Scholar
  • Danylo Rafhael Costa-Silva, Maria da Conceição Barros-Oliveira, Rafael Soares Borges, Larysse Maira Campos-Verdes, João Paulo da Silva-Sampaio, Carla Solange Escorcio-Dourado, Luana Mota Martins, Airlane Pereira Alencar, Edmund Chada Baracat, Vladimir Costa Silva, and Benedito Borges da Silva, “Insulin-like growth factor 1 gene polymorphism in women with breast cancer,” Medical Oncology, vol. 34, no. 4, 2017. View at Publisher · View at Google Scholar
  • Chin-Cheng Lee, Peng-Hsu Chen, Kuo-Hao Ho, Chwen-Ming Shih, Chia-Hsiung Cheng, Cheng-Wei Lin, Kur-Ta Cheng, Ann-Jeng Liu, and Ku-Chung Chen, “The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA,” Plos One, vol. 12, no. 3, pp. e0173890, 2017. View at Publisher · View at Google Scholar
  • Ferenc Sipos, Hajnal Székely, Imre Dániel Kis, Zsolt Tulassay, and Györgyi Műzes, “Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer,” World Journal of Gastroenterology, vol. 23, no. 46, pp. 8109–8119, 2017. View at Publisher · View at Google Scholar
  • Juan Du, Yu Yu, Jun Zhan, and Hongquan Zhang, “Targeted Therapies Against Growth Factor Signaling in Breast Cancer,” Translational Research in Breast Cancer, vol. 1026, pp. 125–146, 2017. View at Publisher · View at Google Scholar
  • Panagiotis F. Christopoulos, Alexandre Corthay, and Michael Koutsilieris, “Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics,” Cancer Treatment Reviews, 2017. View at Publisher · View at Google Scholar
  • Laura A. Smith, Ciara H. O’Flanagan, Laura W. Bowers, Emma H. Allott, and Stephen D. Hursting, “Translating Mechanism-Based Strategies to Break the Obesity−Cancer Link: A Narrative Review,” Journal of the Academy of Nutrition and Dietetics, 2017. View at Publisher · View at Google Scholar
  • Babisan Askari, Nahid Bijeh, and Amir Rashid Lamir, “Effects of 8 Weeks of Resistance Training and IGF-1 Injection on Biochemical Markers of Cancer and Colorectal Structures in Rats,” Medical Laboratory Journal, vol. 11, no. 6, pp. 23–29, 2017. View at Publisher · View at Google Scholar
  • Ayman Yosry, Dalia Omran, Mohamad Yousef, Olfat Shaker, Yahya Elsherif, Mohamad Salah, Heba Omar, Sherif Hamdy, and Mohamad S. Marie, “SNPs in the insulin-like growth factor gene and obesity impact on colorectal cancer in Egyptians,” Asian Pacific Journal of Cancer Prevention, vol. 18, no. 11, pp. 2959–2964, 2017. View at Publisher · View at Google Scholar
  • Zimple Kurlawala, Rain Dunaway, Parag P. Shah, Julie A. Gosney, Leah J. Siskind, Brian P. Ceresa, and Levi J. Beverly, “Regulation of insulin-like growth factor receptors by Ubiquilin1,” Biochemical Journal, vol. 474, no. 24, pp. 4105–4118, 2017. View at Publisher · View at Google Scholar
  • Haitao Wang, Xiaoying Su, Jiankang Fang, Xingan Xin, Xia Zhao, Uma Gaur, Qiang Wen, Jiangping Xu, Peter Little, and Wenhua Zheng, “Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways,” International Journal of Molecular Sciences, vol. 19, no. 9, pp. 2719, 2018. View at Publisher · View at Google Scholar
  • Chifei Kang, Derek LeRoith, and Emily J Gallagher, “Diabetes, Obesity, and Breast Cancer,” Endocrinology, vol. 159, no. 11, pp. 3801–3812, 2018. View at Publisher · View at Google Scholar
  • Stanley B. DeVore, Coleman H. Young, Guangyuan Li, Anitha Sundararajan, Thiruvarangan Ramaraj, Joann Mudge, Faye Schilkey, Aaron Muth, Paul R. Thompson, and Brian D. Cherrington, “Histone Citrullination Represses MicroRNA Expression, Resulting in Increased Oncogene mRNAs in Somatolactotrope Cells,” Molecular and Cellular Biology, vol. 38, no. 19, 2018. View at Publisher · View at Google Scholar
  • Hannaneh monirinasab, Hamed Asadi, Kobra Rostamizadeh, Abdolreza Esmaeilzadeh, Malihe Khodaei, and Mojtaba Fathi, “Novel lipid-polymer hybrid nanoparticles for siRNA delivery and IGF-1R gene silencing in breast cancer cells,” Journal of Drug Delivery Science and Technology, 2018. View at Publisher · View at Google Scholar
  • Chengjian Tu, Michael V. Fiandalo, Elena Pop, John J. Stocking, Gissou Azabdaftari, Jun Li, Hua Wei, Danjun Ma, Jun Qu, James L. Mohler, Li Tang, and Yue Wu, “Proteomic Analysis of Charcoal-Stripped Fetal Bovine Serum Reveals Changes in the Insulin-like Growth Factor Signaling Pathway,” Journal of Proteome Research, 2018. View at Publisher · View at Google Scholar
  • Leo Cabistany, Victor Silveira Coswig, Fabricio Boscolo Del Vecchio, and Rafael Bueno Orcy, “Correction to:Testosterone-mediated activation of androgenic signaling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines,” Sport Sciences for Health, vol. 14, no. 2, pp. 433–438, 2018. View at Publisher · View at Google Scholar
  • Fuminori Kimura, Shunichiro Tsuji, and Takashi Murakami, “Molecular Pathogenesis of Uterine Fibroids,” Uterine Fibroids and Adenomyosis, pp. 37–57, 2018. View at Publisher · View at Google Scholar
  • S. Giannattasio, F. Megiorni, V. Di Nisio, A. Del Fattore, R. Fontanella, S. Camero, C. Antinozzi, C. Festuccia, G. L. Gravina, S. Cecconi, C. Dominici, L. Di Luigi, C. Ciccarelli, P. De Cesaris, A. Riccioli, B. M. Zani, A. Lenzi, R. G. Pestell, A. Filippini, C. Crescioli, V. Tombolini, and F. Marampon, “Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines,” Journal of Endocrinological Investigation, 2018. View at Publisher · View at Google Scholar
  • Zhizhen Chen, Weizao Chen, Dimiter S. Dimitrov, Qi Zhao, Hongmin Zhang, Xiaohua Douglas Zhang, Yaming Shan, Guixing Ma, Pu Wang, Qiang Chen, Chuxia Deng, Jie Liu, and Dafeng Chu, “A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells,” International Journal of Biological Sciences, vol. 14, no. 7, pp. 799–806, 2018. View at Publisher · View at Google Scholar
  • Pamela Imperadore, Ortrud Uckermann, Roberta Galli, Gerald Steiner, Matthias Kirsch, and Graziano Fiorito, “ Nerve regeneration in the cephalopod mollusc Octopus vulgaris: label-free multiphoton microscopy as a tool for investigation ,” Journal of The Royal Society Interface, vol. 15, no. 141, pp. 20170889, 2018. View at Publisher · View at Google Scholar
  • Huilin Ye, Zhiqiang Shen, Le Yu, Mei Wei, and Ying Li, “Manipulating nanoparticle transport within blood flow through external forces: an exemplar of mechanics in nanomedicine,” Proceedings of the Royal Society A: Mathematical, Physical and Engineering Science, vol. 474, no. 2211, pp. 20170845, 2018. View at Publisher · View at Google Scholar
  • Quanwei Zhang, Qi Wang, Jishang Gong, Jiaxing Du, Yong Zhang, and Xingxu Zhao, “Yak IGF2 Promotes Fibroblast Proliferation Via Suppression of IGF1R and PI3KCG Expression,” Genes, vol. 9, no. 3, pp. 169, 2018. View at Publisher · View at Google Scholar
  • Ayse Ceren Mutgan, H. Erdinc Besikcioglu, Shenghan Wang, Helmut Friess, Güralp O. Ceyhan, and Ihsan Ekin Demir, “Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer,” Molecular Cancer, vol. 17, no. 1, 2018. View at Publisher · View at Google Scholar
  • Ishanya Ayeshini Abeyagunawardena, Arundhi Abeynayake, Thushani Anuththara, Kasun Alawaththegama, Sakuni Amanda, Vishaka Abeyrathne, Prabhadi Amaradasa, Buddhika Anuradha, Hanan Ahmed, Chathupa Abeykoon, and Dinesh Malcolm Gerard Fernando, “Is it appropriate to use WHO Multicentre Growth Reference Study standards to assess the growth parameters of Sri Lankan babies? A single-centre cross-sectional study,” BMJ Paediatrics Open, vol. 2, no. 1, pp. e000174, 2018. View at Publisher · View at Google Scholar
  • Sahana Vasudevan, and Asmita A. Prabhune, “Photophysical studies on curcumin-sophorolipid nanostructures: applications in quorum quenching and imaging,” Royal Society Open Science, vol. 5, no. 2, pp. 170865, 2018. View at Publisher · View at Google Scholar
  • Ahmad Abu-Khader, Kyle W. Law, Suria Jahan, Javed K. Manesia, Roya Pasha, Owen Hovey, and Nicolas Pineault, “Paracrine Factors Released by Osteoblasts Provide Strong Platelet Engraftment Properties,” Stem Cells, 2018. View at Publisher · View at Google Scholar
  • Una Glamočlija, Subhash Padhye, Selma Špirtović-Halilović, Amar Osmanović, Elma Veljović, Sunčica Roca, Irena Novaković, Boris Mandić, Iztok Turel, Jakob Kljun, Snežana Trifunović, Emira Kahrović, Sandra Kraljević Pavelić, Anja Harej, Marko Klobučar, and Davorka Završnik, “Synthesis, Biological Evaluation and Docking Studies of Benzoxazoles Derived from Thymoquinone,” Molecules, vol. 23, no. 12, pp. 3297, 2018. View at Publisher · View at Google Scholar
  • Ilze Mentoor, Anna-Mart Engelbrecht, Paul J. van Jaarsveld, and Theo Nell, “Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment,” Frontiers in Endocrinology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Paola Chiodelli, Chiara Urbinati, Giulia Paiardi, Eugenio Monti, and Marco Rusnati, “Sialic acid as a target for the development of novel antiangiogenic strategies,” Future Medicinal Chemistry, 2018. View at Publisher · View at Google Scholar
  • Cesar Luiz Boguszewski, and Margaret Cristina da Silva Boguszewski, “Growth Hormone’s Links to Cancer,” Endocrine Reviews, vol. 40, no. 2, pp. 558–574, 2018. View at Publisher · View at Google Scholar
  • Ilze Mentoor, A-M Engelbrecht, and Theo Nell, “Fatty Acids: Adiposity and Breast Cancer Chemotherapy, A bad synergy?,” Prostaglandins, Leukotrienes and Essential Fatty Acids, 2018. View at Publisher · View at Google Scholar
  • Jacintha O’Sullivan, Joanne Lysaght, Claire L. Donohoe, and John V. Reynolds, “Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments,” Nature Reviews Gastroenterology & Hepatology, 2018. View at Publisher · View at Google Scholar
  • Marie-Lisa Eich, Aline C. Tregnago, Sheila F. Faraj, Doreen N. Palsgrove, Kazutoshi Fujita, Stephania M. Bezerra, Enrico Munari, Rajni Sharma, Alcides Chaux, and George J. Netto, “Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma,” Virchows Archiv, 2018. View at Publisher · View at Google Scholar
  • Yudi Geng, Cong Sui, Yang Xun, Qiaohong Lai, and Lei Jin, “MiRNA-99a can regulate proliferation and apoptosis of human granulosa cells via targeting IGF-1R in polycystic ovary syndrome,” Journal of Assisted Reproduction and Genetics, 2018. View at Publisher · View at Google Scholar
  • Mônica R. Gadelha, Leandro Kasuki, Dawn S.T. Lim, and Maria Fleseriu, “Systemic complications of acromegaly and the impact of the current treatment landscape: An update,” Endocrine Reviews, vol. 40, no. 1, pp. 268–332, 2018. View at Publisher · View at Google Scholar
  • Yasukiyo Murakami, Kazumasa Matsumoto, Masaomi Ikeda, Takuji Utsunomiya, Takahiro Hirayama, Dai Koguchi, Daisuke Matsuda, Norihiko Okuno, Yoshinori Taoka, Akira Irie, and Masatsugu Iwamura, “Impact of body mass index on the oncological outcomes of patients with upper and lower urinary tract cancers treated with radical surgery: A multi-institutional retrospective study,” Asia-Pacific Journal of Clinical Oncology, 2018. View at Publisher · View at Google Scholar
  • Stella A. Child, Elise F. Naumann, John B. Bruning, and Stephen G. Bell, “ Structural and functional characterisation of the cytochrome P450 enzyme CYP268A2 from Mycobacterium marinum ,” Biochemical Journal, vol. 475, no. 4, pp. 705–722, 2018. View at Publisher · View at Google Scholar
  • Elham Jafari, Ali Gheysarzadeh, Karim Mahnam, Rezvan Shahmohammadi, Amir Ansari, Hadi Bakhtyari, and MohammadReza Mofid, “In silico interaction of insulin-like growth factor binding protein 3 with insulin-like growth factor 1,” Research in Pharmaceutical Sciences, vol. 13, no. 4, pp. 332, 2018. View at Publisher · View at Google Scholar
  • Antonella Profumo, Carla Renata Arciola, Livia Visai, Daniele Merli, and Paolo Quadrelli, “Drug delivery systems for chemotherapeutics through selected polysaccharidic vehicles,” Current Organic Chemistry, vol. 22, no. 12, pp. 1157–1192, 2018. View at Publisher · View at Google Scholar
  • Livia Manzella, Michele Massimino, Stefania Stella, Elena Tirrò, Maria Stella Pennisi, Federica Martorana, Gianmarco Motta, Silvia Rita Vitale, Adriana Puma, Chiara Romano, Sandra Di Gregorio, Marco Russo, Pasqualino Malandrino, and Paolo Vigneri, “Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment,” International Journal of Molecular Sciences, vol. 20, no. 13, pp. 3258, 2019. View at Publisher · View at Google Scholar
  • Sonia Reimondez-Troitiño, José V. González-Aramundiz, Juan Ruiz-Bañobre, Rafael López-López, María J. Alonso, Noemi Csaba, and María de la Fuente, “Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells,” European Journal of Pharmaceutics and Biopharmaceutics, 2019. View at Publisher · View at Google Scholar
  • Fen Jiang, Xiao-Li Xu, and Qi-Dong You, “HSP90 Inhibitors Blocking Multiple Oncogenic Signaling Pathways for the Treatment of Cancer,” Heat Shock Proteins in Signaling Pathways, vol. 17, pp. 397–429, 2019. View at Publisher · View at Google Scholar
  • Yu-Lei Hou, Peng Luo, Guang-yan Ji, and Hui Chen, “Clinical significance of serum IGFBP-3 in colorectal cancer,” Journal of Clinical Laboratory Analysis, pp. e22912, 2019. View at Publisher · View at Google Scholar
  • Hanna Lawnicka, Ewelina Motylewska, Magdalena Borkowska, Krzysztof Kuzdak, Agnieszka Siejka, Jacek Swietoslawski, Henryk Stepien, and Tomasz Stepien, “Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers,” Biomedical Papers, 2019. View at Publisher · View at Google Scholar
  • Mansour Poorebrahim, Matin Asghari, Soodabeh Derakhshandeh, Mohammad Foad Abazari, Hassan Askari, Hadi Hassannia, Sahar Heydari, Pegah Ghoraeian, Fatemeh Abutalebi, Maryam Nouri Aleagha, Mohammad Hossein Nasr-Esfahani, and Kianoush Dormiani, “An engineered analog of insulin-like growth factor 1 with reduced immunogenicity and retained mitogenicity,” Biochemical Engineering Journal, 2019. View at Publisher · View at Google Scholar
  • Murat Sari, Senem Karabulut, Süleyman Bademler, Alişan Zirtiloğlu, and Ceren Tilgen Yasasever, “IGF-1 and IGFBP-3 in colorectal cancer, an observational case-control study,” Acta Medica Mediterranea, vol. 35, no. 1, pp. 15–21, 2019. View at Publisher · View at Google Scholar